Reports for SUN PHARMA CANADA INC

Company Name

SUN PHARMA CANADA INC

Totals

Shortage reports

467

Actual shortage: 34 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 6 (1%)
Resolved: 427 (91%)

Discontinuation Reports

41

To be discontinued: 0 (0%)
Discontinued: 41 (100%)
Reversed: 0 (0%)

Late reports

292 (57%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TARO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-05-09 178195
TARO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-11-03 2024-05-09 173678
TARO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-11-16 2024-05-09 175041
TARO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-12-08 2025-12-08 273719
TARO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-05-09 178202
TARO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-09-09 178205
TARO-ZOPICLONE 7.5MG TABLET Resolved 2020-10-08 2020-12-03 125962

Showing 461 to 467 of 467

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TARO-ZOPICLONE 7.5MG TABLET Discontinued 2021-06-16 2021-06-17 141043

Showing 41 to 41 of 41